US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 13, 2022 (4 years ago)

Medroxyprogesterone acetate injectable suspension, USP, 150 mg/mL, 1 mL vials, packaged…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP deviations: Temperature abuse

What was recalled

Medroxyprogesterone acetate injectable suspension, USP, 150 mg/mL, 1 mL vials, packaged in a) single dose vial (NDC 0703-6801-01), b) 25-count box single dose vials (NDC 0703-6801-04), Rx only, MFG: Teva Pharma USA

Recalling firm
Mckesson Medical-Surgical Inc. Corporate Office
NDC code
0703-6801-01
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1069-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Progesterone recalls

See all